Table 3 Early and late adverse events
From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry
Variablesa | Early (≤6 months) | Late (>6 months) |
|---|---|---|
Thromboembolism | 1 (0.6) | 2 (1.1) |
Stroke | 0 | 2 (1.1) |
TIA | 1 (0.6) | 0 |
Valve thrombosis | 0 | 0 |
Hemolysis | 0 | 0 |
Major bleeding | 1 (0.6) | 0 |
Non-structural valve dysfunction | 0 | 1 (0.6) |
Paravalvular leak | Â | Â |
 Minor | 6 (3.4) | 6 (3.4) |
 Major | 1 (0.6) | 0 |
Structural valve deterioration | 0 | 0 |
Endocarditis | 3 (1.7) | 2 (1.1) |
Prosthesis explant | 2 (1.1) | 1 (0.6) |
Mortality Valve-related | 1 (0.6) | 0 |